Adelaide BioMed City is the largest health and medical research precinct in the southern hemisphere. As a hub for health and life sciences, it co-locates institutions from research, education and clinical care in a precinct in the heart of Adelaide.

The goal of the $3.8 billion Adelaide BioMed City is to build impact, leverage investment and inform evidence-based healthcare and innovation. It will facilitate the full lifecycle of medical research, from basic discovery, clinical, public health to health services to improve the health of South Australians and people everywhere.

Adelaide BioMed City is home to:

The Australian Bragg Centre for Proton Therapy and Research will soon join the Adelaide BioMed City. This new building, expected to be completed in 2023, will house Australia’s first proton therapy unit, and the first of its kind in the southern hemisphere. The centre will also be an integral part in a global network undertaking proton therapy research.